HLA alleles, COVID-19 vaccine antibody response and real-world breakthrough outcomes by Xie, J, Mothe, B, Herraiz, MA, Li, C, Xu, Y, Jödicke, AM, Gao, Y, Feng, S, Wei, J, Chen, Z, Hong, S, Wu, Y, Su, B, Zheng, X, Cohet, C, Ali, R, Wareham, N, Prieto-Alhambra, D

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five Eur... by Li, X, Burn, E, Duarte-Salles, T, Yin, C, Reich, C, Delmestri, A, Verhamme, K, Rijnbeek, P, Suchard, MA, Li, K, Mosseveld, M, John, LH, Mayer, M-A, Ramirez-Anguita, J-M, Cohet, C, Strauss, V, Prieto-Alhambra, D

Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes by Xie, J, Mothe, B, Alcalde Herraiz, M, Li, C, Xu, Y, Jödicke, AM, Gao, Y, Wang, Y, Feng, S, Wei, J, Chen, Z, Hong, S, Wu, Y, Su, B, Zheng, X, Cohet, C, Ali, R, Wareham, N, Prieto Alhambra, D

Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States by Lo Re III V, Cocoros NM, Hubbard RA, Dutcher SK, Newcomb CW, Connolly JG, Perez-Vilar S, Carbonari DM, Kempner ME, Hernández-Muñoz JJ, Petrone AB, Pishko AM, Rogers Driscoll ME, Brash JT, Burnett S, Cohet C, Dahl M, DeFor TA, Delmestri A, Djibo DA, Duarte-Salles T, Harrington LB, Kampman M, Kuntz JL, Kurz X, Mercadé-Besora N, Pawloski PA, Rijnbeek PR, Seager S, Steiner CA, Verhamme K, Wu F, Zhou Y, Burn E, Paterson JM, Prieto-Alhambra D

Get full text